Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Acta Biomaterialia|March 9, 2010
Anticoagulant activity of enzymatically synthesized amylose derivatives containing carboxy or sulfonate groupsJun-ichi Takahara, Kayo Hosoya, Michihiro Sunako, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Persistent effects of delayed treatment with nefiracetam on the water maze task in rats with sustained cerebral ischemiaSatoshi Takeo, Tomoko Fukatsu, Keiko Miyake-Takagi, et al.
Nanoscale|July 10, 2025
Dispersion of carbon nanotubes triggered by the helical self-assembly of poly(methyl methacrylate)Ayaka D Inoue, Kazuhiro Yoshida, Tsuyoshi Ando, et al.
Clinical Chemistry|February 20, 2015
Noncompetitive immunoassay detection system for haptens on the basis of antimetatype antibodiesKazuya Omi, Tsuyoshi Ando, Takuya Sakyu, et al.
British Journal of Pharmacology|February 25, 2003
A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in ratsSatoshi Takeo, Makiko Niimura, Keiko Miyake-Takagi, et al.
Biomaterials Science|December 9, 2014
Utilization of star-shaped polymer architecture in the creation of high-density polymer brush coatings for the prevention of platelet and bacteria adhesionMasayasu Totani, Tsuyoshi Ando, Kayo Terada, et al.
European Journal of Pharmacology|October 24, 2002
Effects of nefiracetam on spatial memory function and acetylcholine and GABA metabolism in microsphere-embolized ratsTomoko Fukatsu, Keiko Miyake-Takagi, Akira Nagakura, et al.
Biological & Pharmaceutical Bulletin|March 4, 2003
Effects of nefiracetam on cerebral adenylyl cyclase activity in rats with microsphere embolism-induced memory dysfunctionSatoshi Takeo, Keiko Miyake-Takagi, Kanako Kikuchi, et al.
Biological & Pharmaceutical Bulletin|December 2, 2008
Structure-photodynamic effect relationships of 24 glycoconjugated photosensitizers in HeLa cellsShiho Hirohara, Makoto Obata, Hiroki Alitomo, et al.
Journal of Bone and Mineral Metabolism|August 28, 2016
Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: a 156-week longitudinal observational study in daily practiceSatoshi Soen, Takashi Umemura, Tsuyoshi Ando, et al.
Pageof 5